Stevioside targets the NF-κB and MAPK pathways for inhibiting inflammation and apoptosis of chondrocytes and ameliorates osteoarthritis in vivo
International Immunopharmacology · 2023-02 · 115 · 109683
DOI: 10.1016/j.intimp.2023.109683 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-02. Verfasst von Tingwen Cai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, C…. Hauptthemen laut MEDLINE: Osteoarthritis, Cartilage, Articular. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Medical Science and Technology Project of Zhejiang Province.
Abstract (Originalsprache)
Osteoarthritis (OA) is a joint disease that is characterized by articular cartilage degeneration and destruction. Stevioside (SVS) is a diterpenoid glycoside extracted from Stevia rebaudiana Bertoni with some specific effects against inflammatory and apoptotic, whereas it is still unclear what function SVS has in osteoarthritis. This study focuses on the anti-inflammatory and anti-apoptosis functions of SVS on chondrocytes induced by interleukin (IL)-1beta, and the role of SVS in an osteoarthritis model for mice. We can detect the production of inflammatory factors such as nitric oxide (NO) and prostaglandin E2 (PGE2) using real-time quantitative polymerase chain reaction (RT-qPCR), the Griess reaction, and enzyme linked immunosorbent assay (ELISA). On the basis of Western blot, we have observed the protein expressions of cartilage matrix metabolism, inflammatory factors, and apoptosis of chondrocytes. Simultaneously, the pharmacological effects of SVS in mice were evaluated by hematoxylin and eosin (HE), toluidine blue, Safranin O, and immunohistochemical staining. The results show that SVS slows extracellular matrix degradation and chondrocyte apoptosis. In addition, SVS mediates its cellular effect by inhibiting the activation of mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) signaling pathways. Meanwhile, molecular docking studies revealed that SVS has excellent binding capabilities to p65, extracellular signal-regulated kinase (ERK), p38, and c-Jun N-terminal kinase (JNK). The study suggests that SVS can be developed as a potential osteoarthritis treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China; Key Laboratory of Orthopedics of Zhejiang Province, Wenzhou, Zhe…
- Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
- Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China. Electronic address: xiaoyunpan@126.com.
- Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China. Electronic address: linj0208@163.com.
Förderung
- Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
- Medical Science and Technology Project of Zhejiang Province
Zitieren
APA
Cai, T., Ye, H., Jiang, H., Lin, C., Lou, C., Wang, W., Yan, Z., Xue, X., Pan, X., & Lin, J. (2023). Stevioside targets the NF-κB and MAPK pathways for inhibiting inflammation and apoptosis of chondrocytes and ameliorates osteoarthritis in vivo. International Immunopharmacology, 115, 109683. https://doi.org/10.1016/j.intimp.2023.109683
Vancouver
Cai T, Ye H, Jiang H, Lin C, Lou C, Wang W, et al. Stevioside targets the NF-κB and MAPK pathways for inhibiting inflammation and apoptosis of chondrocytes and ameliorates osteoarthritis in vivo. International Immunopharmacology. 2023;115:109683. doi:10.1016/j.intimp.2023.109683
BibTeX
@article{Cai2023,
author = {Cai, Tingwen and Ye, Hantao and Jiang, Hongyi and Lin, Chihao and Lou, Chao and Wang, Weidan and Yan, Zijian and Xue, Xinghe and Pan, Xiaoyun and Lin, Jian},
title = {Stevioside targets the NF-κB and MAPK pathways for inhibiting inflammation and apoptosis of chondrocytes and ameliorates osteoarthritis in vivo},
journal = {International Immunopharmacology},
year = {2023},
volume = {115},
pages = {109683},
doi = {10.1016/j.intimp.2023.109683}
}
EUVIMED